首站-论文投稿智能助手
典型文献
Advances in traditional Chinese medicine for liver disease therapy in 2021
文献摘要:
Liver diseases and their co-morbidities represent a major public health problem.Owing to its progressive pathogenesis and lack of effective treatment,liver disease has become one of the most important causes of death worldwide.Traditional Chinese medicine(TCM)has potential advantages in the prevention and treatment of liver diseases,including high safety,remarkable curative effects,and low toxicity and side effects.In 2021,TCM extracts and their derivatives,TCM compounds,and ethnic medicines showed good efficacy in the treatment of liver diseases.The main mechanisms and representative drugs of TCM can be summarized by the use of amygdalin,dicoumarol,quercetin,and ancient ephedrine decoction to treat hepatitis by inhibiting viral replication,as well as the use of Gentianae Radix,lupeol,Zornia diphylla(L.)Pers.,and Chinese patent medicine Liuwei Wuling tablet to alleviate acute liver injury by improving oxidative stress and inflammatory responses in the body.In the treatment of alcoholic liver disease and metabolic-associated fatty liver disease,the mechanism of TCM is the inhibition of oxidative stress,improving metabolism,regulating intestinal microflora,and enhancing intestinal barrier function.The representative TCM for alcoholic liver disease includes astragaloside,puerarin,patchouli alcohol,and Mori Fructus polysaccharide,while those for metabolic-associated fatty liver disease include saikosaponin,dehydroabietic acid,hesperetin,berberine,and Panax Notoginseng saponins.Additionally,germacrone,forsythin,geniposide,and protocatechuic acid can inhibit the activation or migration of stellate cells and improve liver fibrosis.Toosendanin,paeoniflorin,chrysin,and the classical prescription Huanglian decoction can significantly inhibit the proliferation of liver cancer cells and promote their apoptosis for the treatment of hepatocellular carcinoma.The activation of the farnesol X receptor pathway can improve bile metabolism in the liver,thus,significantly alleviating cholestatic liver disease.Its representative drugs include the TCM extracts pterostilbene and arbutin.In this review,we summarize the advances made in research on TCM used in the treatment of liver diseases in 2021,providing a reference for further development of TCM for the prevention and treatment of liver diseases.
文献关键词:
作者姓名:
Jun-Yu Luo;Jia-Bao Liao;Yu-Ming Wang;Jie Zhao;Xue-Hua Xie;Fei Qu;Xi-Xing Fang;Wei-Bo Wen;Shu-Quan Lyu
作者机构:
Yunnan University of Traditional Chinese Medicine,Kunming 650500,China;Jiaxing Hospital of Traditional Chinese Medicine,Jiaxing 314033,China;Tianjin University of Traditional Chinese Medicine,Tianjin 300000,China;Changchun University of Traditional Chinese Medicine,Changchun 130117,China;Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine in Hebei Province,Cangzhou 061001,China
引用格式:
[1]Jun-Yu Luo;Jia-Bao Liao;Yu-Ming Wang;Jie Zhao;Xue-Hua Xie;Fei Qu;Xi-Xing Fang;Wei-Bo Wen;Shu-Quan Lyu-.Advances in traditional Chinese medicine for liver disease therapy in 2021)[J].传统医学研究(英文版),2022(06):92-109
A类:
dicoumarol,ephedrine,Gentianae,Zornia,diphylla,Liuwei,patchouli,dehydroabietic,Notoginseng,germacrone,forsythin,Toosendanin,chrysin,farnesol
B类:
Advances,traditional,Chinese,liver,therapy,Liver,diseases,their,morbidities,major,public,health,problem,Owing,its,progressive,pathogenesis,lack,effective,treatment,has,become,most,important,causes,death,worldwide,Traditional,TCM,potential,advantages,prevention,including,high,safety,remarkable,curative,effects,low,toxicity,In,extracts,derivatives,compounds,ethnic,medicines,showed,good,efficacy,main,mechanisms,representative,drugs,summarized,by,amygdalin,quercetin,ancient,decoction,hepatitis,inhibiting,viral,replication,well,Radix,lupeol,Pers,patent,Wuling,tablet,alleviate,acute,injury,improving,oxidative,stress,inflammatory,responses,body,alcoholic,metabolic,associated,fatty,inhibition,metabolism,regulating,intestinal,microflora,enhancing,barrier,function,includes,astragaloside,puerarin,Mori,Fructus,polysaccharide,while,those,saikosaponin,acid,hesperetin,berberine,Panax,saponins,Additionally,geniposide,protocatechuic,activation,migration,stellate,cells,improve,fibrosis,paeoniflorin,classical,prescription,Huanglian,significantly,proliferation,cancer,promote,apoptosis,hepatocellular,carcinoma,receptor,pathway,bile,thus,alleviating,cholestatic,Its,pterostilbene,arbutin,this,review,advances,made,research,used,providing,reference,further,development
AB值:
0.517925
相似文献
Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-κB pathway activation
Shuyin Bao;Xiuzhi Wang;Qianqian Ma;Chengxi Wei;Jixing Nan;Wuliji Ao-Institute of Pharmaceutical Chemistry and Pharmacology,Inner Mongolia Minzu University,Tongliao 028000,China;Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System,Tongliao 028000,China;Jilin Key Laboratory for Traditional Chinese Korean Medicine,College of Pharmacy,Yanbian University,Yanji 133002,China;Department of Medicines and Foods,Tongliao Vocational College,Tongliao 028000,China;Research and development center,Inner Mongolia Research Institute of Traditional Mongolian Medicine Engineering Technology,Tongliao 028000,China;Mongolian Medicine R&D National Local Union Engineering Research Center,Inner Mongolia Minzu University,Tongliao 028000,China
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD:A promising drug Potentilla discolor Bunge
Longshan Ji;Qian Li;Yong He;Xin Zhang;Zhenhua Zhou;Yating Gao;Miao Fang;Zhuo Yu;Robim M.Rodrigues;Yueqiu Gao;Man Li-Laboratory of Cellular Immunity,Institute of Clinical Immunology,Shanghai Key Laboratory of Traditional Chinese Medicine,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Key Laboratory of Liver and Kidney Diseases(Shanghai University of Traditional Chinese Medicine),Ministry of Education,Shanghai 201203,China;Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Hepatopathy,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of in Vitro Toxicology and Dermato-Cosmetology,Faculty of Medicine and Pharmacy,Vrije Universiteit Brussel,Brussels 1000,Belgium
Effect of astragaloside Ⅳ and salvianolic acid B on antioxidant stress and vascular endothelial protection in the treatment of atherosclerosis based on metabonomics
KONG Xiang-Lin;LYU Qin;ZHANG Ya-Qi;KANG Dong-Fang;LI Chao;ZHANG Lei;GAO Zi-Chen;LIU Xin-Xin;WU Ji-Biao;LI Yun-Lun-Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan 250355, China;Graduate School,Liaoning University of Traditional Chinese Medicine,Shenyang 110847,China;College of Continuing Education,Shandong University of Traditional Chinese Medicine,Jinan,250355,China;Innovative Institute of Chinese Medicine and Pharmacy,Shandong University of Traditional Chinese Medicine,Jinan 250355,China;College of Traditional Chinese Medicine,Shandong University of Traditional Chinese Medicine,Jinan 250355,China;Department of Cardiology,the Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250011,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。